(19)
(11) EP 1 141 339 A1

(12)

(43) Date of publication:
10.10.2001 Bulletin 2001/41

(21) Application number: 99968572.0

(22) Date of filing: 29.12.1999
(51) International Patent Classification (IPC)7C12N 15/63, C12N 15/64, C12N 15/864, C12N 15/12, C12N 5/10, A61K 48/00
(86) International application number:
PCT/US9931/220
(87) International publication number:
WO 0039/311 (06.07.2000 Gazette 2000/27)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 31.12.1998 US 114596 P

(71) Applicant: Advanced Research & Technology Institute
Indianapolis,Indiana 46202-2156 (US)

(72) Inventors:
  • SRIVASTAVA, Arun
    Indianapolis, IN 46228 (US)
  • QING, Keyun
    Indianapolis, IN 46226 (US)
  • MAH, Cathryn
    Indianapolis, IN 46254 (US)
  • HANSEN, Jonathan
    Indianapolis, IN 46214 (US)
  • ZHOU, Shangzhen
    Alameda, CA 94502 (US)
  • DWARKI, Varavani
    Alameda, CA 94502 (US)

(74) Representative: Lawrence, John 
Barker Brettell 138 Hagley RoadEdgbaston
Birmingham B16 9PW
Birmingham B16 9PW (GB)

   


(54) HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 1 IS A CO-RECEPTOR FOR INFECTION BY ADENO-ASSOCIATED VIRUS 2